Japan · Delayed Price · Currency is JPY Organo Statistics
Total Valuation
Organo has a market cap or net worth of JPY 578.69 billion. The enterprise value is 582.93 billion.
| Market Cap | 578.69B |
| Enterprise Value | 582.93B |
Important Dates
The last earnings date was Friday, October 31, 2025.
| Earnings Date | Oct 31, 2025 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
Organo has 45.98 million shares outstanding. The number of shares has increased by 0.04% in one year.
| Current Share Class | 45.98M |
| Shares Outstanding | 45.98M |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 0.24% |
| Owned by Institutions (%) | 23.27% |
| Float | 25.49M |
Valuation Ratios
The trailing PE ratio is 21.00 and the forward PE ratio is 19.69.
| PE Ratio | 21.00 |
| Forward PE | 19.69 |
| PS Ratio | 3.37 |
| PB Ratio | 4.50 |
| P/TBV Ratio | 4.55 |
| P/FCF Ratio | 43.22 |
| P/OCF Ratio | 37.12 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.90, with an EV/FCF ratio of 43.53.
| EV / Earnings | 21.16 |
| EV / Sales | 3.39 |
| EV / EBITDA | 14.90 |
| EV / EBIT | 15.69 |
| EV / FCF | 43.53 |
Financial Position
The company has a current ratio of 3.07, with a Debt / Equity ratio of 0.16.
| Current Ratio | 3.07 |
| Quick Ratio | 2.34 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 0.53 |
| Debt / FCF | 1.55 |
| Interest Coverage | 146.90 |
Financial Efficiency
Return on equity (ROE) is 23.25% and return on invested capital (ROIC) is 16.31%.
| Return on Equity (ROE) | 23.25% |
| Return on Assets (ROA) | 12.31% |
| Return on Invested Capital (ROIC) | 16.31% |
| Return on Capital Employed (ROCE) | 26.18% |
| Revenue Per Employee | 64.56M |
| Profits Per Employee | 10.35M |
| Employee Count | 2,660 |
| Asset Turnover | 0.91 |
| Inventory Turnover | 4.55 |
Taxes
In the past 12 months, Organo has paid 9.59 billion in taxes.
| Income Tax | 9.59B |
| Effective Tax Rate | 25.82% |
Stock Price Statistics
The stock price has increased by +47.54% in the last 52 weeks. The beta is 0.99, so Organo's price volatility has been similar to the market average.
| Beta (5Y) | 0.99 |
| 52-Week Price Change | +47.54% |
| 50-Day Moving Average | 12,424.80 |
| 200-Day Moving Average | 9,249.65 |
| Relative Strength Index (RSI) | 46.06 |
| Average Volume (20 Days) | 367,130 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Organo had revenue of JPY 171.74 billion and earned 27.54 billion in profits. Earnings per share was 599.15.
| Revenue | 171.74B |
| Gross Profit | 62.16B |
| Operating Income | 37.02B |
| Pretax Income | 37.16B |
| Net Income | 27.54B |
| EBITDA | 39.00B |
| EBIT | 37.02B |
| Earnings Per Share (EPS) | 599.15 |
Balance Sheet
The company has 16.53 billion in cash and 20.77 billion in debt, giving a net cash position of -4.24 billion or -92.10 per share.
| Cash & Cash Equivalents | 16.53B |
| Total Debt | 20.77B |
| Net Cash | -4.24B |
| Net Cash Per Share | -92.10 |
| Equity (Book Value) | 128.64B |
| Book Value Per Share | 2,797.54 |
| Working Capital | 110.73B |
Cash Flow
In the last 12 months, operating cash flow was 15.59 billion and capital expenditures -2.20 billion, giving a free cash flow of 13.39 billion.
| Operating Cash Flow | 15.59B |
| Capital Expenditures | -2.20B |
| Free Cash Flow | 13.39B |
| FCF Per Share | 291.20 |
Margins
Gross margin is 36.20%, with operating and profit margins of 21.56% and 16.04%.
| Gross Margin | 36.20% |
| Operating Margin | 21.56% |
| Pretax Margin | 21.64% |
| Profit Margin | 16.04% |
| EBITDA Margin | 22.71% |
| EBIT Margin | 21.56% |
| FCF Margin | 7.80% |
Dividends & Yields
This stock pays an annual dividend of 190.00, which amounts to a dividend yield of 1.51%.
| Dividend Per Share | 190.00 |
| Dividend Yield | 1.51% |
| Dividend Growth (YoY) | 18.75% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 26.73% |
| Buyback Yield | -0.04% |
| Shareholder Yield | 1.47% |
| Earnings Yield | 4.76% |
| FCF Yield | 2.31% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 29, 2022. It was a forward split with a ratio of 4.
| Last Split Date | Sep 29, 2022 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
Organo has an Altman Z-Score of 6.46 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.46 |
| Piotroski F-Score | 6 |